Administration & Faculty

Amber V. Buhler, PhD

Associate Professor

503-352-7294
abuhler@pacificu.edu

 

Education

2006  Postdoctoral Intern,

Neurosciences Pain Research Program,

Merck Inc. and Co.,

West Point, Pennsylvania

2001-2006  Postdoctoral Fellow,

Dept. of Pharmacology and Pain Research Group,

University of Iowa

2001  Doctor of Philosophy,

Pharmacology,

University of Colorado

1995  Bachelor of Art, Chemistry,

California State University, Fresno

1995  Bachelor of Art, Functional Biology,

California State University, Fresno

 

Areas of Research & Specialization

Dr. Buhler has a specialization in neuropharmacology. Interest areas include the neuroscience of pain modulation and mental illness. Current laboratory research focuses on neuronal circuits involved in the modulation of pain. Dr. Buhler welcomes undergraduate and Pharmacy students in her lab.

 

Publications

2013   Kate Wagner, Zach Roeder, Keith DesRochers, Amber V. K. Buhler, Mary M. Heinricher, Daniel R. Cleary. “The dorsomedial hypothalamus increases pain sensitivity via CCK containing projections to the rostral ventromedial medulla.” Neuroscience, 238:29-38.

2011   Amber V. Buhler, Katie Farrell, David Fuentes, BJ Scott, Kelli Shaffer, and Mary Von.  An interprofessional case conference on Alzheimer's disease: teaching students in the health professions to work together. Journal of Interprofessional Care, 25(3):223-225.

 

2010   Reza Karimi, Cassandra Arendt, Pauline Cawley, Amber V. Buhler, Fawzy Elbarbry, and Sigrid Roberts.  Learning bridge: curricular integration of didactic and experiential education. American Journal of Pharmaceutical Education, 74(3) Article 48.

2008   A.V. Buhler and Reza Karimi.  Peer-level patient presenters decrease pharmacy students' social distance from patients with schizophrenia and clinical depression.  American Journal of Pharmaceutical Education, 72 (5) Article 106.     

 

2008   A.V. Buhler, H.K. Proudfit and G.F. Gebhart.  Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine.  Pain, 135(3):280-90.

2006    L. Zhang, K.T. Sykes, A.V. Buhler, D.L. Hammond.  Electrophysiological heterogeneity of spinally projecting serotonergic and nonserotonergic neurons in the rostral ventromedial medulla. Journal of Neurophysiology, 95(3):1853-63.

2005    A.V. Buhler, J. Choi, H.K. Proudfit and G.F. Gebhart.  Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive.  Pain, 114(1-2):285-94.

2004    A.V. Buhler, H.K. Proudfit and G.F. Gebhart.  Separate populations of neurons in the rostral ventromedial medulla project to the spinal cord and to the dorsolateral pons in the rat.   Brain Research, 1016:12-19.

2002    A.V. Buhler, T.V. Dunwiddie.  Alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. Journal of Neurophysiology, 87(1):548-557.

2001    A.V. Buhler, T.V. Dunwiddie.  Regulation of the activity of hippocampal stratum oriens interneurons by alpha7 nicotinic acetylcholine receptors.  Neuroscience, 106 (1):55-67.

1998    C.J. Frazier, A.V. Buhler, J.L. Weiner, and T.V. Dunwiddie.  Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons.  Journal of Neuroscience, 18(20):8228-8235.

1998    J.L. Weiner, A.V. Buhler, V.J. Whatley, R.A. Harris, and T.V. Dunwiddie.  Colchicine is a competitive antagonist at human recombinant gamma-aminobutyric acidA receptors. Journal of Pharmacology and Experimental Therapeutics, 284:95-102.

 

 

Back to Administration & Faculty Listing